Request Discount

Exosomes Market (Applications - Neurodegenerative Diseases, Oncology, Cardiovascular Diseases, Infectious Diseases, and Genetic Disorders; End-user - Hospitals, Diagnostic Centers, Cancer Institutes, and Research Laboratories): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : June, 2019

  • Rep Id : HC0541

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Exosomes Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Exosomes Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Exosomes Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on exosomes market provides in-depth analysis of segments and sub-segments in the global as well as regional exosomes market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional exosomes market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global exosomes market. According to the report, the global exosomes market is projected to grow at a CAGR of 17.5% over the forecast period of 2019-2025.


Global Exosomes Market

 

Market Insight

Exosomes are extracellular vesicles that are made of the phospholipid bilayer. They are enclosed vesicles from eukaryotic cells. Exosomes are secreted by almost all cell types, they are found in urine, saliva, serum, plasma, amniotic fluid, and other biological fluids. They act as messengers between the cells conveying a message to the distant cells. Exosomes carry nucleic acids, protein, and lipids from cell to cell. Exosomes are unique in nature and it has a wide variety of functions, the most interesting function of exosome is cell communication and cell signaling. Exosomes have adaptive immune responses to tumors and pathogens. Exosomes are used for diagnosis of diseases like cancer, neurodegenerative disorders, and other human pathological conditions.


The growing adoption of exosomes in production of biomarkers, therapeutics and non-invasive diagnostics since the last five years is heading the development of exosomes market. Exosomes are quantified in human plasma and other biological fluids for the diagnosis of malignant and benign tumors. Furthermore, there is a surge of innovation with respect to the unexplored area of exosomes in research and development. The rapid growth of cancer and neurodegenerative disease and the use of exosomes in the diagnosis of cancer is contributing to the growth of exosomes in the diagnostics and therapeutics segment. It allows the detection and monitoring of disorder at an early stage. However, the major restraint for the growth of exosomes is the lack of skilled professionals and the high cost of therapies. Moreover, due to growing awareness about exosomes for disease diagnosis and the rising technological advancements in biomarkers are projected to create growth opportunities for the exosomes market over the forecast period.


Amongst to geographies, North America has the maximum share in the exosomes market. The major factors contributing to the growth of this region are high occurrences of cancer and an increasing number of clinical trials in countries such as the U.S. and Canada. Europe holds the second position owing to technical advances in healthcare. The Asia Pacific is the fastest-growing region. The increased rate of neurodegenerative diseases, resulting in increased diagnosis and the rising investments in research and development from several established healthcare companies are the factors contributing to the growth of the Asia Pacific exosome market.


Segment Covered

The report on global exosomes market covers segments such as applications, and end-user. On the basis of applications, the sub-markets include neurodegenerative diseases, oncology, cardiovascular diseases, infectious diseases, and genetic disorders. On the basis of end-user, the sub-markets include hospitals, diagnostic centers, cancer institutes, and research laboratories.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Bio-Techne Corporation, Takara Bio Company, Codiak BioSciences Inc., Evox Therapeutics Limited, ExCoBio Inc., ArunA Bio, Inc. Kimera Society Inc., Aegle Therapeutics Corporation and Anjarium Biosciences AG.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of exosomes market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. 


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount